Breaking Barriers: Myeloma Patient Experience and Insights on Challenges in CAR T-Cell Therapy

What gets in the way of choosing CAR T-cell therapy for multiple myeloma patients? What barriers did you face?
What support helped—or didn’t?

Your experience could help remove these obstacles for future patients.

Go directly to survey

STUDY IMPACT

CAR T-cell therapy is a groundbreaking treatment for relapsed and refractory multiple myeloma (RRMM). Yet despite its potential, many patients encounter challenges when considering or accessing it. This study seeks to understand your personal experience—whether you moved forward with CAR T or not.

By participating, you'll help identify:

• Common barriers to accessing CAR T
• Emotional, financial, or logistical factors influencing decisions
• Gaps in education, referrals, or provider communication
• What support systems helped—or what was missing
• How to better prepare and guide patients during the decision process

Your insights will be used to improve access, enhance support, and inform real solutions for others considering CAR T in the future.

HOW TO PARTICIPATE

1. Sign in or create a free Cure Hub account
2. Complete the survey (takes about 10 minutes)

WHO CAN JOIN

You are eligible to participate if you are 18 years or older, have been diagnosed with multiple myeloma, and have ever considered CAR T-cell therapy—even if it was just a conversation with your doctor.

Join the Study Today